アジア太平洋地域の皮膚充填剤の市場規模は、2022年に10億ドルと評価されました。皮膚充填剤市場業界は、2023 年の 10 億 6,000 万ドルから 2032 年までに 18 億ドルに成長し、予測期間 (2023 年から 2032 年) の間に 6.80% のCAGRを示すと予測されます。非侵襲的な美容整形に対する需要の高まり、顔の若返りを求める高齢人口の増加、皮膚充填技術の進歩が、市場の成長を促進する主要な市場推進要因となっています。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. ASIA PACIFIC DERMAL FILLERS MARKET, BY TYPE
6.1. Overview
6.2. Hyaluronic acid (HA)
6.3. Calcium Hydroxylapatite (CaHA)
6.4. Poly L lactic Acid
6.5. Others
7. ASIA PACIFIC DERMAL FILLERS MARKET, BY GENDER
7.1. Overview
7.2. Male
7.3. Female
8. ASIA PACIFIC DERMAL FILLERS MARKET, BY SERVICE PROVIDER
8.1. Overview
8.2. Specialty and Dermatology Clinics
8.3. Hospitals
8.4. Others
9. ASIA PACIFIC DERMAL FILLERS MARKET, BY COUNTRY
9.1. Overview
9.2. China
9.3. India
9.4. Japan
9.5. South Korea
9.6. SouthEast Asia
9.7. Rest of Asia
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the ASIA PACIFIC DERMAL FILLERS Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the ASIA PACIFIC DERMAL FILLERS Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Cutera Inc.
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. GALDERMA SA.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Teoxane Laboratories
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Sinclair Pharma
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Revance Therapeutics
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Elan aesthetics Inc
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. VITAL ESTHETIQUE LABORATORIES
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Merz Pharma GmbH
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Bioxis pharmaceutical
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. AbbVie Laboratories
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 ASIA PACIFIC DERMAL FILLERS MARKET, SYNOPSIS, 2018-2032
TABLE 2 ASIA PACIFIC DERMAL FILLERS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 ASIA PACIFIC DERMAL FILLERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 ASIA PACIFIC DERMAL FILLERS MARKET, BY GENDER, 2018-2032 (USD BILLION)
TABLE 5 ASIA PACIFIC DERMAL FILLERS MARKET, BY SERVICE PROVIDER, 2018-2032 (USD BILLION)
TABLE 6 CHINA DERMAL FILLERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 7 CHINA DERMAL FILLERS MARKET, BY GENDER, 2018-2032 (USD BILLION)
TABLE 8 CHINA DERMAL FILLERS MARKET, BY SERVICE PROVIDER, 2018-2032 (USD BILLION)
TABLE 9 INDIA, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 INDIA DERMAL FILLERS MARKET, BY GENDER, 2018-2032 (USD BILLION)
TABLE 11 INDIA DERMAL FILLERS MARKET, BY SERVICE PROVIDER, 2018-2032 (USD BILLION)
TABLE 12 JAPAN DERMAL FILLERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 13 JAPAN DERMAL FILLERS MARKET, BY GENDER, 2018-2032 (USD BILLION)
TABLE 14 JAPAN DERMAL FILLERS MARKET, BY SERVICE PROVIDER, 2018-2032 (USD BILLION)
TABLE 15 SOUTH KOREA DERMAL FILLERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 16 SOUTH KOREA DERMAL FILLERS MARKET, BY GENDER, 2018-2032 (USD BILLION)
TABLE 17 SOUTH KOREA DERMAL FILLERS MARKET, BY SERVICE PROVIDER, 2018-2032 (USD BILLION)
TABLE 18 SOUTHEAST ASIA DERMAL FILLERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 19 SOUTHEAST ASIA DERMAL FILLERS MARKET, BY GENDER, 2018-2032 (USD BILLION)
TABLE 20 SOUTHEAST ASIA DERMAL FILLERS MARKET, BY SERVICE PROVIDER, 2018-2032 (USD BILLION)
TABLE 21 REST OF ASIA PACIFIC DERMAL FILLERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 22 REST OF ASIA PACIFIC DERMAL FILLERS MARKET, BY GENDER, 2018-2032 (USD BILLION)
TABLE 23 REST OF ASIA PACIFIC DERMAL FILLERS MARKET, BY SERVICE PROVIDER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE ASIA PACIFIC DERMAL FILLERS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE ASIA PACIFIC DERMAL FILLERS MARKET
FIGURE 4 ASIA PACIFIC DERMAL FILLERS MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 ASIA PACIFIC DERMAL FILLERS MARKET, SHARE (%), BY GENDER, 2022
FIGURE 6 ASIA PACIFIC DERMAL FILLERS MARKET, SHARE (%), BY SERVICE PROVIDER, 2022
FIGURE 7 ASIA PACIFIC DERMAL FILLERS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 8 CUTERA INC. : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 9 CUTERA INC. : SWOT ANALYSIS
FIGURE 10 GALDERMA SA.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 11 GALDERMA SA.: SWOT ANALYSIS
FIGURE 12 TEOXANE LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 TEOXANE LABORATORIES: SWOT ANALYSIS
FIGURE 14 SINCLAIR PHARMA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 SINCLAIR PHARMA: SWOT ANALYSIS
FIGURE 16 REVANCE THERAPEUTICS.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 REVANCE THERAPEUTICS.: SWOT ANALYSIS
FIGURE 18 ELAN AESTHETICS INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 ELAN AESTHETICS INC: SWOT ANALYSIS
FIGURE 20 VITAL ESTHETIQUE LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 VITAL ESTHETIQUE LABORATORIES: SWOT ANALYSIS
FIGURE 22 MERZ PHARMA GMBH.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MERZ PHARMA GMBH.: SWOT ANALYSIS
FIGURE 24 BIOXIS PHARMACEUTICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BIOXIS PHARMACEUTICAL: SWOT ANALYSIS
FIGURE 26 ABBVIE LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ABBVIE LABORATORIES: SWOT ANALYSIS
Source: https://www.marketresearchfuture.com/reports/asia-pacific-dermal-fillers-market/toc
